Table 7.
Frequently reported symptoms by time between testing and survey receipt (n = 2539)
3–9 months (n = 765) | 10–12 months (n = 1073) | More than 12 months (n = 701) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 test result | COVID-19 test result | COVID-19 test result | |||||||||||||
Symptomw | Positive | Negative | Odds Ratio | Positive | Negative | Odds ratio | Positive | Negative | Odds ratio | ||||||
Na | % | Na | % | [95% CI] | Na | % | Na | % | [95% CI] | Na | % | Na | % | [95% CI] | |
General symptoms | |||||||||||||||
Fatigue/Tiredness | 247 | 58.7 | 129 | 38.4 | 2.29 [1.64–3.21] | 422 | 60.9 | 173 | 46.8 | 1.78 [1.34–2.35] | 159 | 56.2 | 159 | 38.4 | 2.25 [1.59–3.20] |
Muscle & body aches | 167 | 39.7 | 83 | 24.9 | 2.11 [1.48–3.03] | 240 | 34.9 | 95 | 25.7 | 1.52 [1.12–2.07] | 106 | 37.5 | 102 | 24.6 | 1.82 [1.25–2.65] |
Joint pains | 158 | 37.5 | 80 | 24.1 | 2.12 [1.48–3.04] | 238 | 34.6 | 85 | 23.0 | 1.83 [1.34–2.52] | 101 | 35.7 | 98 | 23.7 | 2.24 [1.52–3.32] |
Shortness of breath | 130 | 30.8 | 56 | 16.7 | 2.14 [1.46–3.17] | 211 | 30.6 | 55 | 14.9 | 2.43 [1.72–3.46] | 87 | 31.0 | 47 | 11.4 | 4.16 [2.65–6.65] |
Cough | 118 | 28.2 | 62 | 18.5 | 1.49 [1.01–2.21] | 170 | 24.8 | 66 | 17.9 | 1.57 [1.12–2.21] | 69 | 24.6 | 87 | 21.0 | 1.25 [0.82–1.89] |
Brain & nervous system | |||||||||||||||
Headaches | 207 | 50.1 | 116 | 35.4 | 1.74 [1.24–2.44] | 328 | 49.2 | 150 | 41.6 | 1.32 [0.99–1.75] | 138 | 50.5 | 138 | 34.2 | 1.69 [1.17–2.44] |
Concentration problems | 210 | 50.2 | 99 | 30.1 | 2.70 [1.92–3.83] | 343 | 51.2 | 107 | 29.6 | 2.49 [1.86–3.36] | 135 | 48.9 | 105 | 26.0 | 2.58 [1.79–3.74] |
Memory problems | 173 | 41.6 | 69 | 20.9 | 2.98 [2.08–4.32] | 264 | 39.4 | 75 | 20.8 | 2.41 [1.76–3.33] | 97 | 35.3 | 71 | 17.6 | 2.26 [1.53–3.37] |
General weakness | 122 | 29.3 | 54 | 16.5 | 2.06 [1.39–3.09] | 178 | 26.6 | 55 | 15.2 | 2.17 [1.53–3.14] | 69 | 25.1 | 61 | 15.1 | 1.83 [1.18–2.84] |
Dizziness | 104 | 25.1 | 56 | 17.0 | 1.56 [1.04–2.34] | 165 | 24.8 | 53 | 14.7 | 1.90 [1.33–2.74] | 63 | 22.7 | 58 | 14.4 | 1.73 [1.12–2.68] |
Balance problems | 99 | 24.1 | 55 | 16.8 | 1.89 [1.25–2.87] | 158 | 23.5 | 44 | 12.2 | 2.37 [1.61–3.54] | 47 | 17.0 | 58 | 14.4 | 1.57 [0.97–2.53] |
Mental well-being | |||||||||||||||
Difficulty sleeping | 219 | 52.8 | 131 | 39.7 | 1.67 [1.20–2.32] | 342 | 51.0 | 158 | 44.3 | 1.21 [0.91–1.60] | 144 | 52.4 | 167 | 42.2 | 1.30 [0.91–1.84] |
Anxiety | 216 | 51.9 | 138 | 41.9 | 1.55 [1.09–2.20] | 333 | 50.0 | 174 | 48.7 | 0.92 [0.69–1.24] | 142 | 51.8 | 162 | 40.8 | 1.26 [0.88–1.80] |
Depression | 173 | 41.8 | 99 | 29.9 | 1.90 [1.34–2.72] | 253 | 37.7 | 122 | 34.0 | 1.07 [0.79–1.46] | 88 | 32.1 | 117 | 29.5 | 0.91 [0.62–1.34] |
Ears, nose, and throat | |||||||||||||||
Congested nose | 180 | 43.0 | 95 | 28.4 | 1.81 [1.29–2.55] | 240 | 35.2 | 125 | 33.8 | 1.09 [0.82–1.45] | 91 | 32.4 | 127 | 30.9 | 1.02 [0.71–1.47] |
Ringing in ears | 104 | 24.9 | 69 | 21.4 | 1.30 [0.89–1.92] | 163 | 24.1 | 72 | 19.6 | 1.23 [0.88–1.72] | 72 | 25.6 | 73 | 17.8 | 1.91 [1.27–2.90] |
Heart or circulation | |||||||||||||||
Irregular heartbeats | 96 | 23.0 | 41 | 12.5 | 2.42 [1.57–3.89] | 172 | 25.5 | 51 | 13.9 | 1.95 [1.37–2.81] | 70 | 25.1 | 61 | 15.0 | 1.85 [1.21–2.85] |
Leg pain when walking | 102 | 24.6 | 50 | 15.2 | 2.13 [1.41–3.27] | 153 | 22.6 | 45 | 12.3 | 2.11 [1.45–3.14] | 55 | 19.8 | 50 | 12.3 | 1.70 [1.05–2.77] |
Eyes or vision | |||||||||||||||
Dry eyes | 123 | 29.6 | 80 | 24.2 | 1.63 [1.13–2.36] | 185 | 27.2 | 96 | 26.4 | 1.11 [0.81–1.53] | 74 | 26.9 | 85 | 20.8 | 1.72 [1.15–2.58] |
Stomach or digestion | |||||||||||||||
Heartburn (reflux) | 120 | 28.9 | 62 | 18.7 | 1.82 [1.25–2.67] | 178 | 26.4 | 73 | 19.9 | 1.45 [1.04–2.02] | 73 | 26.4 | 84 | 20.7 | 1.17 [0.78–1.76] |
aResponder (Reported yes symptom); Odds ratio and 95% confidence interval by Logistic Regression adjusted for age, sex, BMI, vaccine status, race/ethnicity, CCI, and time after COVID-19 test, respectively.